Article Type
Changed
Tue, 05/21/2019 - 12:14
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

Sponsor
Funding for this newsletter series was provided by AstraZeneca
Publications
Topics
Sections
Sponsor
Funding for this newsletter series was provided by AstraZeneca
Sponsor
Funding for this newsletter series was provided by AstraZeneca

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

Publications
Publications
Topics
Article Type
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Off